1. Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol. 1990; 109:298–302.
Article
2. Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999; 106:2054–62.
Article
3. Uemoto R, Nakasato-Sonn H, Kawagoe T, et al. Factors associated with enlargement of chorioretinal atrophy after intravitreal abdominal for myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2012; 250:989–97.
4. Tsuiki E, Suzuma K, Ueki R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion. Am J Ophthalmol. 2013; 156:543–7.e1.
Article
5. Shin YU, Lee MJ, Lee BR. Choroidal maps in different types of macular edema in branch retinal vein occlusion using swept-source optical coherence tomography. Am J Ophthalmol. 2015; 160:328–34.e1.
Article
6. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in abdominal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011; 118:840–5.
7. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009; 148:445–50.
Article
8. Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009; 29:1469–73.
Article
9. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina. 2011; 31:1603–8.
Article
10. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness abdominal treatment of Vogt-Koyanagi-Harada disease. Retina. 2011; 31:510–7.
11. Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2011; 151:594–603.e1.
Article
12. Du KF, Xu L, Shao L, et al. Subfoveal choroidal thickness in retinal vein occlusion. Ophthalmology. 2013; 120:2749–50.
Article
13. Yuan A, Ahmad BU, Xu D, et al. Comparison of intravitreal abdominal and bevacizumab for the treatment of macular edema abdominal to retinal vein occlusion. Int J Ophthalmol. 2014; 7:86–91.
14. Campochiaro PA, Sophie R, Pearlman J, et al. abdominal outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014; 121:209–19.
15. Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of abdominal endothelial growth factor in retinal cells. Arch Ophthalmol. 1995; 113:1538–44.
16. Ku DD, Zaleski JK, Liu S, et al. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993; 265(2 Pt 2):H586–92.
Article
17. Tilton RG, Chang KC, LeJeune WS, et al. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by abdominal VEGF. Invest Ophthalmol Vis Sci. 1999; 40:689–96.
18. Ferrara N. Vascular endothelial growth factor: molecular and abdominal aspects. Curr Top Microbiol Immunol. 1999; 237:1–30.
19. Jirarattanasopa P, Ooto S, Tsujikawa A, et al. Assessment of abdominal choroidal thickness by optical coherence tomography and abdominalgraphic changes in central serous chorioretinopathy. Ophthalmology. 2012; 119:1666–78.